Quanta Dialysis Technologies
UK - WarwickBiotechnology
Focus: Quanta Dialysis Technologies develops advanced dialysis systems for renal failure treatment, focusing on nephrology innovation in the UK biotechnology sector.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
3
Should You Work at Quanta Dialysis Technologies?
AI assessmentOnly pursue if you thrive in high-risk, early-stage environments with founders building a focused dialysis technology platform and can tolerate extreme resource constraints.
Why Work Here
- Early-stage opportunity to shape a specialized nephrology device platform with only 3 active roles, enabling meaningful impact on product development
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
SC+ Hemodialysis System
Renal FailureClinical Trials (1)
NCT04975880Quanta Home Run Trial
N/AHelp build intelligence for Quanta Dialysis Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.